Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

42.45USD
3:20pm EDT
Change (% chg)

$0.28 (+0.66%)
Prev Close
$42.17
Open
$42.72
Day's High
$42.85
Day's Low
$41.82
Volume
82,121
Avg. Vol
113,691
52-wk High
$46.81
52-wk Low
$26.17

Latest Key Developments (Source: Significant Developments)

REPLIGEN CORP ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK
Monday, 26 Jun 2017 05:12pm EDT 

June 26 (Reuters) - Repligen Corp :REPLIGEN CORPORATION ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK.HAS COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $100 MILLION IN SHARES OF ITS COMMON STOCK.  Full Article

Repligen and Spectrum to join forces
Friday, 23 Jun 2017 07:00am EDT 

June 23 (Reuters) - Repligen Corp ::Repligen Corporation and spectrum, inc. To join forces.Repligen Corp - deal expected to be accretive to repligen earnings per share in fiscal 2018.Repligen corp says deal for approximately $359 million.Repligen Corp says deal comprised of $120 million in cash plus 6,154,000 shares of repligen stock.Repligen Corp - to fund transaction, repligen intends to use its cash on hand, which totaled approximately $142 million on march 31, 2017.Repligen Corp - spectrum is expected to add $17 million to $18 million to repligen revenue in 2017.Repligen Corp - to fund transaction by potentially a committed debt financing of $30 million that it has obtained from JPMorgan Chase Bank, N.A.Repligen - for full year 2018, spectrum is expected to grow double-digit and contribute $47 million to $50 million in incremental revenue.Repligen - for full year 2018, spectrum is expected to grow double-digit and contribute $47 to $50 million in incremental revenue.Repligen - three-year total synergies as a result of deal are expected to be in range of $20 to $25 million.Repligen - repligen expects deal to be breakeven to adjusted eps in 2017 and accretive to both gaap and adjusted eps in 2018.  Full Article

Repligen reports Q1 GAAP earnings per share $0.09
Thursday, 4 May 2017 07:30am EDT 

May 4 (Reuters) - Repligen Corp : :Repligen reports first quarter 2017 financial results.Q1 adjusted non-GAAP earnings per share $0.15.Q1 GAAP earnings per share $0.09.Q1 revenue $30.6 million versus I/B/E/S view $29.6 million.Q1 earnings per share view $0.13 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $0.55, revenue view $122.7 million -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $0.55 to $0.60.Raises FY 2017 GAAP earnings per share view to $0.36 to $0.41.Sees FY 2017 revenue $121 million to $126 million.Adjusting income tax guidance and increasing net income and eps guidance for year 2017.Repligen says otherwise maintaining financial guidance as provided on feb 22 earnings call.  Full Article

Repligen posts Q4 adj. earnings per share $0.08
Wednesday, 22 Feb 2017 07:30am EST 

Repligen Corp : Repligen reports fourth quarter 2016 financial results, provides guidance for 2017 . Sees FY 2017 adjusted earnings per share $0.54 to $0.59 . Sees FY 2017 GAAP earnings per share $0.35 to $0.40 . Q4 adjusted non-GAAP earnings per share $0.08 . Q4 GAAP earnings per share $0.15 . Sees FY 2017 revenue $121 million to $126 million . Q4 revenue $25.6 million . Q4 earnings per share view $0.07 -- Thomson Reuters I/B/E/S .FY2017 earnings per share view $0.55, revenue view $123.3 million -- Thomson Reuters I/B/E/S.  Full Article

Repligen reports Q2 earnings per share $0.11
Thursday, 4 Aug 2016 07:30am EDT 

Repligen Corp : Q2 earnings per share $0.11 . Q2 non-GAAP earnings per share $0.16 . Q2 earnings per share view $0.13 -- Thomson Reuters I/B/E/S . Q2 revenue $29.2 million versus I/B/E/S view $24.8 million . Sees FY 2016 GAAP earnings per share $0.23 to $0.29 . Sees FY 2016 adjusted earnings per share $0.42 to $0.48 . Sees FY 2016 revenue $101 million to $105 million .FY2016 earnings per share view $0.47, revenue view $99.4 million -- Thomson Reuters I/B/E/S.  Full Article

Repligen announces pricing of $100 mln of 2.125 pct convertible senior notes due 2021
Thursday, 19 May 2016 08:41am EDT 

Repligen Corp :Repligen announces pricing of $100 million of 2.125 pct convertible senior notes due 2021.  Full Article

Repligen Corp files for mixed shelf offering - SEC filing
Wednesday, 18 May 2016 06:05pm EDT 

Repligen Corp : Repligen Corp files for mixed shelf offering, size not disclosed Source - http://bit.ly/1WExHpA Further company coverage: [RGEN.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

Repligen to offer $100 mln of convertible senior notes
Wednesday, 18 May 2016 04:20pm EDT 

Repligen Corp :Repligen announces proposed public offering of $100 million of convertible senior notes due 2021.  Full Article

Repligen Corp announces extension of long term supply agreement for Protein A
Wednesday, 24 Feb 2016 04:59pm EST 

Repligen Corp:Announces extension of long term supply agreement for protein a.Says has extended through 2019 a key long-term supply agreement with GE healthcare for the manufacture of protein a ligands.  Full Article

Repligen Corp raises FY 2015 revenue guidance
Thursday, 6 Aug 2015 07:30am EDT 

Repligen Corp:Sees FY 2015 revenue to be in the range of $78-$82 million, an increase from previous guidance of $75-$78 million.Says revenue projection for FY 2015 is comprised exclusively of bioprocessing product sales.  Full Article

BRIEF-Repligen prices public offering of shares of common stock

* Repligen Corporation prices public offering of shares of common stock